엠폭스 백신 및 치료제 시장 규모, 점유율, 성장 분석 : 유형별, 유통경로별, 지역별 - 업계 예측(2026-2033년)

Global Monkeypox Vaccine And Treatment Market size was valued at USD 682.5 Million in 2024 and is poised to grow from USD 744.06 Million in 2025 to USD 1485.4 Million by 2033, growing at a CAGR of 9.02% during the forecast period (2026-2033).

The monkeypox vaccine and treatment market is driven by the increasing prevalence of zoonotic diseases, transforming it into a critical facet of public health. This market encompasses a range of products, including vaccines, antivirals, diagnostic tools, and logistics for prevention and clinical use. Its primary objective is to mitigate morbidity, maintain healthcare capacity, and swiftly contain outbreaks to prevent societal disruptions. Growing awareness and recent multipronged outbreaks have led to heightened regulatory approvals, encouraging more manufacturers to enter the space. National governments and international organizations have ramped up purchases, focusing on outbreak monitoring and flexible regulatory approaches. This shift promotes contract manufacturing, cold-chain logistics, rapid diagnostics, and opens opportunities for licensing and equitable distribution, particularly in resource-limited areas.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Monkeypox Vaccine And Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Monkeypox Vaccine And Treatment Market Segments Analysis

Global monkeypox vaccine and treatment market is segmented by type, distribution and region. Based on type, the market is segmented into Vaccines and Treatments. Based on distribution, the market is segmented into Government Stockpiling, Hospital Pharmacies and Public Health Programs. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Monkeypox Vaccine And Treatment Market

Heightened media coverage and enhanced surveillance initiatives have significantly raised awareness about the risks tied to monkeypox, prompting policymakers and healthcare systems to prioritize the acquisition of vaccines and treatments. The growing urgency and perceived threat associated with the disease encourage governments and international organizations to dedicate resources toward research, stockpiling, and distribution strategies. This collective response indicates to manufacturers an increased demand, encouraging them to boost production capacities and enhance supply chains. Collaborative efforts between public and private sectors foster partnerships that streamline clinical development processes and reinforce procurement commitments, ultimately driving market growth through amplified demand and reduced commercial uncertainty for vaccine and treatment providers.

Restraints in the Global Monkeypox Vaccine And Treatment Market

The global monkeypox vaccine and treatment market faces significant restraints primarily due to the rigorous requirements for vaccine production and specialty therapeutics. The need for highly skilled personnel and advanced manufacturing facilities that adhere to strict biosafety standards creates substantial barriers to entry for new manufacturers. As a result, these challenges can lead to supply bottlenecks and prolong timelines for scaling production, ultimately preventing some companies from advancing their product development. Furthermore, the concentration of manufacturing capacity among a small number of established suppliers heightens the risks of supply disruptions and reduces competitive dynamics, culminating in limited product availability and restricted market access for potential new entrants.

Market Trends of the Global Monkeypox Vaccine And Treatment Market

The Global Monkeypox Vaccine and Treatment market is witnessing a significant trend towards decentralized delivery infrastructure, enhancing accessibility and efficiency in healthcare delivery systems. This approach emphasizes the establishment of community-based clinics and mobile units, enabling rapid responses to localized outbreaks. Furthermore, the integration of flexible cold-chain solutions and digital appointment scheduling is fostering an agile healthcare environment, enhancing trust in the system by utilizing familiar delivery points. These strategies not only improve patient-centered care but also strengthen the resilience of supply chains, facilitating better coordination between national programs and local providers for effective prevention and treatment of monkeypox.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Monkeypox Vaccine And Treatment Market Size by Type & CAGR (2026-2033)

• Market Overview
• Vaccines
  • JYNNEOS (MVA-BN)
  • ACAM2000
• Treatments
  • Tecovirimat (TPOXX)
  • Cidofovir
  • Brincidofovir

Global Monkeypox Vaccine And Treatment Market Size by Distribution & CAGR (2026-2033)

• Market Overview
• Government Stockpiling
• Hospital Pharmacies
• Public Health Programs

Global Monkeypox Vaccine And Treatment Market Size by Region & CAGR (2026-2033)

• Market Overview
• North America
• Europe
• Africa
• Asia-Pacific

Global Monkeypox Vaccine And Treatment Market Size & CAGR (2026-2033)

• North America (Type, Distribution, Region)
  • US
  • Canada
• Europe (Type, Distribution, Region)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Distribution, Region)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Distribution, Region)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Distribution, Region)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Bavarian Nordic (JYNNEOS)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIGA Technologies (TPOXX)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chimerix (Brincidofovir)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tonix Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valneva SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeoVax Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iBio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations